Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day…

Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign

The Brand’s Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use…

XJTLU-Baidu AI joint venture launched

SUZHOU, China, March 31, 2025 /PRNewswire/ — On 26 March, Suzhou Pudu Co-Intelligence Technology…

Harbour BioMed Reports Full Year 2024 Financial Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ — Harbour BioMed…

MEXC Unveils MNT Promotion Offering Up to $1 Million in Rewards

VICTORIA, Seychelles, March 31, 2025 /PRNewswire/ — MEXC, a leading global cryptocurrency…

Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement Ingredients

SINGAPORE, March 31, 2025 /PRNewswire/ — Allozymes, a leader in protein engineering,…

PXPay Plus and J.P Morgan Asset Management Taiwan Join Forces to Launch Industry-First Direct Fund Dividend Direct Deposit into E-Wallet Accounts

Endless Growth of Wealth: Reinvest Dividends into Micro-Investment Funds TAIPEI, March 31,…

Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women

Sensoril® Ashwagandha is among Kerry’s portfolio of solutions tailored to meet women’s…